KalVista Pharmaceuticals
KALV
KALV
88 hedge funds and large institutions have $265M invested in KalVista Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 29 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
-3
Holders Change %
-3.3%
% of All Funds
1.41%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
17
Increased
23
Reduced
29
Closed
20
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$1.01M
Top Buyers
Top Sellers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$9.75M |
2 |
Morgan Stanley
New York
|
-$5.05M |
3 |
PVI
Pura Vida Investments
New York
|
-$4.95M |
4 |
TCM
Tang Capital Management
San Diego,
California
|
-$4.28M |
5 |
WP
Woodline Partners
San Francisco,
California
|
-$4.01M |